OXO-IMIDAZOLIDINES AS MODULATORS OF CHEMOKINE RECEPTORS
申请人:Zhang Penglie
公开号:US20080269280A1
公开(公告)日:2008-10-30
Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally monocyclic and bicyclic compounds and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.